FNIH Trailblazer Prize for Clinician-Scientists

image: 

2019 FNIH Trailblazer Prize for Clinician-Scientists

Nomination Deadline:
March 29, 2019
1:00 PM EDT

Eligibility and Nomination Criteria | FAQs

 

 

Overview

In 2018, the Foundation for the National Institutes of Health (FNIH) launched the FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), which recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care. This $10,000 honorarium and prize celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability. The Trailblazer Prize is made possible by a generous donation from John I. Gallin, M.D., and Elaine Gallin, Ph.D., to the FNIH. 

The FNIH recognizes the unique and critical role that clinician-scientists play in the evolution of medical practice. As noted in the 2014 NIH Physician-Scientist Workforce Report, these individuals play a vital role in ensuring that biomedical advances ultimately benefit patients and improve public health. The 2019 Trailblazer Prize will be presented at the FNIH Annual Fall Board Dinner on October 23, 2019 in Washington, D.C.

The awardee will be selected by a jury of distinguished biomedical research leaders including:

  • Michael J. Welsh, M.D., Ph.D., (Jury Chair) Director, Pappajohn Biomedical Institute, University of Iowa
  • Barry Coller, M.D., Vice President for Medical Affairs, Physician in Chief, David Rockefeller Professor
  • Michael Fox, M.D., Ph.D., Associate Professor of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
  • Helen H. Hobbs, M.D., Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center
  • John I. Gallin, M.D., NIH Associate Director for Clinical Research and Chief Scientific Officer of the NIH Clinical Center
  • Crystal Mackall, M.D., Ernest and Amelia Gallo Family Professor of Pediatrics and Internal Medicine, Stanford University
  • Steven M. Paul, M.D., President and Chief Executive Officer, Voyager Therapeutics, Inc. and Venture Partner at Third Rock Ventures

Nominators and/or candidates must not contact any member of the Trailblazer Prize Jury to ask about or discuss any aspect of the prize. If this occurs, the nomination will be withdrawn from the competition.

2018 Recipient

Michael Fox, M.D., Ph.D., Beth Israel Deaconess Medical Center, Harvard Medical School was selected as the recipient of the inaugural FNIH Trailblazer Prize for Clinician-Scientists for developing innovative techniques to map human brain connectivity that can be translated into new treatments for neurological diseases, such as Parkinson’s disease and depression. The inaugural prize was presented at the FNIH Annual Fall Board Dinner on October 24, 2018 in Bethesda, MD.

The finalists for the 2018 Trailblazer Prize included:

  • Dr. Daniel Bauer, M.D., Ph.D., Assistant Professor of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, for pioneering research on genetic editing that can be translated into therapies for blood disorders, such as sickle cell disease and beta-thalassemia.  
  • Dr. Jaehyuk Choi, M.D., Ph.D., Assistant Professor of Dermatology, and of Biochemistry and Molecular Genetics (BMG), Feinberg School of Medicine, Northwestern University, for using genomics to identify mutations in skin cells that can lead to autoinflammatory diseases and cancer, and inspiring novel therapeutic approaches for these diseases.  
  • Dr. Michael Fox, M.D., Ph.D., Associate Professor of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, for developing innovative techniques to map human brain connectivity that can be translated into new treatments for neurological diseases, such as Parkinson’s disease and depression.  

The three finalists spoke at an event held by the FNIH at the Capitol Visitors Center in Washington, D.C. on October 24, 2018 to provide an opportunity for members of Congress and their staff to hear presentations from each of the finalists and to learn more about the role of clinician-scientists in advancing public health.

(Daniel Bauer, M.D., Ph.D., Jaehyuk Choi, M.D., Ph.D., Michael Fox, M.D., Ph.D., Steven M. Paul, M.D.)

 

Media

FNIH Press Release (October 25, 2018): Foundation for the NIH Bestows the Inaugural Trailblazer Prize for Clinician-Scientists to Dr. Michael Fox

FNIH Announcement (July 31, 2018): Foundation for the NIH Selects 3 Finalists for the Inaugural Trailblazer Prize for Clinician-Scientists

Partners

The Trailblazer Prize is supported by John I. Gallin, M.D., and Elaine Gallin, Ph.D.

Contact

Please email TrailblazerPrize@fnih.org with questions.